BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9162539)

  • 1. [Peripheral eosinophilia in ulcerative colitis: apropos of a case].
    Galofre N; Fuste L; Oriol A; Grau J
    Gastroenterol Hepatol; 1997 Mar; 20(3):163. PubMed ID: 9162539
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptogenic fibrosing alveolitis predating ulcerative colitis.
    Pérez de Llano LA; Lancho A; Soilán del Cerro JL; López-Róses L
    Am J Gastroenterol; 1996 Apr; 91(4):822-3. PubMed ID: 8677973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoimmune hemolytic anemia and ulcerative colitis].
    Rebocho L; Lucas M; Victorino RM
    Acta Med Port; 1995 Dec; 8(12):701-3. PubMed ID: 8669321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discussion apropos of a case of ulcerative colitis].
    Loizeau E
    Rev Med Suisse Romande; 1995 Mar; 115(3):263-6. PubMed ID: 7777769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ulcerative colitis. Acute episode].
    Reissmann A; Bischoff SC; Fleig W
    Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-ASA enema therapy.
    Hanauer SB
    Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy.
    McCaulley ME
    J Clin Gastroenterol; 1996 Oct; 23(3):242-3. PubMed ID: 8899515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ulcerative colitis. Maintenance therapy].
    Kruis W; Schreiber S
    Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 12. [New therapeutic data in inflammatory colitis].
    Karsenti P
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
    George J; Present DH; Pou R; Bodian C; Rubin PH
    Am J Gastroenterol; 1996 Sep; 91(9):1711-4. PubMed ID: 8792685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of ulcerative colitis].
    Rückert Y
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):175-9. PubMed ID: 9244661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical treatment of inflammatory bowel disease.
    Singhal A; Kar P
    J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
    [No Abstract]   [Full Text] [Related]  

  • 17. The mesalamine wars heat up-enter balsalazide.
    Cohen RD
    Gastroenterology; 2003 Feb; 124(2):574-5. PubMed ID: 12557164
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of ulcerative colitis with balsalazide: response to editorial by Drs. Farrell and Peppercorn and letter to the editor by Dr. Hanauer.
    Johnson LK; Pruitt RE; Green JR
    Am J Gastroenterol; 2003 Jan; 98(1):216-9. PubMed ID: 12526969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcerative colitis. When is standard therapy enough?].
    Stange EF
    MMW Fortschr Med; 2000 Oct; 142(41):39-40. PubMed ID: 11085075
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.